SUBSTITUTED ISOINDOLIN-1-ONES AND 2,3-DIHYDRO-1H-PYRROL[3,4-c]PYRIDIN-1-ONES AS HPK1 ANTAGONISTS
                        
                            
                                申请人:Nimbus Saturn, Inc.
                            
                            
                                公开号:US20210078997A1
                            
                            
                                公开(公告)日:2021-03-18
                            
                            The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of HPK1, and the treatment of HPK1-mediated disorders.